SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-17-251489
Filing Date
2017-08-08
Accepted
2017-08-08 17:06:21
Documents
9

Document Format Files

Seq Description Document Type Size
1 S-3 d436569ds3.htm S-3 358621
2 EX-1.2 d436569dex12.htm EX-1.2 162252
3 EX-4.4 d436569dex44.htm EX-4.4 35043
4 EX-4.5 d436569dex45.htm EX-4.5 259475
5 EX-5.1 d436569dex51.htm EX-5.1 32921
6 EX-12.1 d436569dex121.htm EX-12.1 7656
7 EX-23.1 d436569dex231.htm EX-23.1 1356
8 GRAPHIC g436569g05i93.jpg GRAPHIC 25870
9 GRAPHIC g436569page0039.jpg GRAPHIC 24372
  Complete submission text file 0001193125-17-251489.txt   927818
Mailing Address 600 CALIFORNIA ST., 17TH FLOOR SAN FRANCISCO CA 94108
Business Address 600 CALIFORNIA ST., 17TH FLOOR SAN FRANCISCO CA 94108 415-638-6556
Audentes Therapeutics, Inc. (Filer) CIK: 0001628738 (see all company filings)

IRS No.: 461606174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-219797 | Film No.: 171015597
SIC: 2836 Biological Products, (No Diagnostic Substances)